secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001437749-24-035433
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key Q3 revenue up 18% to $2.1M; net loss narrows to $0.7M from $1.8M
------------------------------------------------------------------------

- Revenue $2.1M vs $1.8M; license revenue rose 52% to $1.4M on expanded customer deployments.
- Gross margin improved to 78.3% from 18.7%; net loss per share $0.39 vs $3.22 YoY.
- Cash position strengthened to $1.8M at Sep 30 from $0.5M at Dec 31, aided by $1.9M warrant inducement.
- Recent orders: $910k from financial services customer, $500k from defense ministry; 10,000 users added by British Columbia.
- Full-year 2024 revenue expected to meet or exceed $7.75M achieved in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/0001437749-24-035433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924035433/bkyi20241114_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-035433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer